semaglutide swisschems Swissmedic issues warning against falsified and misleading “GLP-1” weight loss products SEMAGLUTIDE

Are seeking clinically proven weight loss support with an FDA-approved medication

Schedule regular appointments to assess glycemic control (through A1C testing), weight changes, and tolerability

At the maximum recommended dose of 15 mg per week, it still provides four full weeks of dosing

Rapid Weight Loss and Telogen Effluvium Ozempic causes rapid weight loss due to appetite suppression, reduced food cravings, and an overall calorie reduction

It is therefore in this context, where treatment options for obesity remain very limited, that the appearance of Ozempic and Mounjaro on the market is currently generating enormous interest, both in the medical and scientific communities and in the general population